Program to give innovators of biologics the strategies and insights
to increase development success
Genocea Biosciences, Inc. describing the development of a subunit
vaccine, comprised of 3 novel proteins with alum adjuvant, from
antigen selection to IND.
Cook Pharmica LLC on the rapid development of a platform from cell
line development to process development and scale-up to manufacturing.
ImmuNext, Inc. on partnering with Pharma at the preclinical stage with
a sponsored research collaboration that exploits the biological
expertise of the biotech start-up and the CMC/RAQ/clinical expertise
of the Pharma partner.
IBC Life Sciences, the organizer of market leading events in drug
discovery and biologics development, today introduced the “Success
Factors for Early Stage Biologicals and Early Stage Companies” program
track at BioProcess International (BPI), October 20-23 at the Hynes
Convention Center in Boston, MA. This new program feature is designed to
provide early stage innovators of biologicals with the insights and
approaches to increase downstream clinical success. The full program
track can be viewed at http://www.ibclifesciences.com/BPI/early-stage.xml.
“Biologic drugs are complex products with complex development processes,
and yet the biggest barriers to efficient development are not technical
- but strategic. Those tasked with conducting the work must understand
and tolerate the risks and challenges that arise during drug
development,” said Mark Moody, Ph.D., Biopharma Consultant and Former
Vice President, Analytical Sciences. “The introduction of the Success
Factors for Early Stage Biologicals and Early Stage Companies track at
BPI will offer much needed strategic and practical advice to innovators
that will help improve their chances of downstream success.”
The program track kicks-off with two feature keynote presentations from
Ganesh V. Kaundinya, Ph.D., Co-Founder and Chief Scientific
Officer, Momenta Pharmaceuticals and Ralph Lambalot, Ph.D., Vice
President, Biologics Development, AbbVie.
To help meet real-world challenges of biological development, the
program also features three case studies by:
Furthering the education of attendees, key presentations will be given
by high-profile executives, including:
“Efficient Biologics Lifecycle Development - Maximizing Value while
Reducing Risk, Time, and Cost”, presented by Mark Moody,
Ph.D., Biopharma Consultant and Former Vice President, Analytical
Sciences, Merrimack Pharmaceuticals.
“Getting More Done with Less: Case Study of An Early Stage Company”
presented by Neil Schauer, Ph.D., Senior Vice President, Technical
Operations, Avaxia Biologics.
“Life in the Fast Lane: Nonclinical Strategies for Accelerating Early
Clinical Proof-Of-Concept for Biologics” presented by Krishna
Allamneni, Ph.D., Executive Director, Nonclinical Development - Early
Development and New Opportunity Assessment, Jazz Pharmaceuticals, Inc.
BioProcess International conference programming is held on October
20-23, 2-day training courses on October 21-22 and the exhibition is
October 21-23. Complete details on this event can be found at www.IBCLifeSciences.com/BPI
or to receive a press pass or arrange an interview with a speaker, email
Dawn O’Connor at email@example.com.
About IBC Life Sciences
IBC Life Sciences, a division of Informa, is your connection to the life
sciences industry. Through conferences, webinars, podcasts and its suite
of integrated marketing solutions, IBC Life Sciences delivers expert
knowledge, valuable connections and customized offerings so customers
can meet their goals. www.IBCLifeSciences.com
IBC Life Sciences hosts the annual BioProcess International™ (BPI)
Conference and Exhibition. The BioProcess International Conference &
Exhibition is where the biologics value chain meets to do business. Each
year BPI attracts over 1500 biologics industry leaders for four days of
power networking and learning. No other industry event delivers the
high-level connections and insight needed to accelerate your business.
Use this preeminent industry platform to showcase your company, products
and thought leadership. To get involved, visit www.IBCLifeSciences.com/BPI
IBC Life Sciences
Dawn O’Connor, 508-614-1679
Source: IBC Life Sciences